Tianjin Medical University General Hospital
Clinical trials sponsored by Tianjin Medical University General Hospital, explained in plain language.
-
Zipper therapy breakthrough: new combo may boost recovery in rare brain disease
Disease control Recruiting nowThis study tests a new treatment called Modified Zipper Therapy for people with a rare disease called NMOSD. It combines standard treatments with a drug called eculizumab to help patients recover better from sudden attacks. About 198 adults will take part to see if this approach …
Phase: PHASE3 • Sponsor: Tianjin Medical University General Hospital • Aim: Disease control
Last updated Jun 05, 2026 12:09 UTC
-
Massive genetic diabetes hunt launches in china
Knowledge-focused Recruiting nowThis study is creating a large digital registry to find and understand rare forms of diabetes caused by a single gene (monogenic diabetes). Researchers will enroll up to 5,000 people in China who were diagnosed with diabetes at a young age and test their DNA. The goal is to learn…
Sponsor: Tianjin Medical University General Hospital • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:06 UTC